Drugs / AICH-PXZY
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03354026 | Nov 2017 → Dec 2022 | intracerebral hemorrhage | Guangzhou University of Traditional Chinese Medicine | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AICH-PXZY | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03354026 ↗ |
| Route | Oral | “po AICH-PXZY bid” NCT03354026 ↗ |